Goodwin
Justin Pierce
- Deals
- 9
- Latest
- Jun 2026
- Most deals in
- Biotech
Firm
- Goodwin Law firm · 2026 · 9 deals
Often works with
- Ai Tajima 6 deals together
- Daniel Karelitz 3 deals together
- Simone Waterbury 3 deals together
- Scott Zilora 3 deals together
- Paul Jin 3 deals together
- Arom Yun 3 deals together
- Justin Shields 3 deals together
- Artimus Cunningham 2 deals together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Jun 2026 | Alloy Enterprises | – | Johnson Controls | Acquisition | Legal adviser to Alloy Enterprises (target) | Announced | – | Manufacturing+2 | Johnson Controls acquisition of Alloy Enterprises |
| Jun 2026 | Topaz Labs | – | Adobe | Acquisition | Legal adviser to Topaz Labs (target) | Announced | – | AI | Adobe acquisition of Topaz Labs |
| Jun 2026 | Kpler | Five Arrows | Sixth Street | Stake | Legal adviser to Kpler (target) | Announced | 1,000.0 | Data & Analytics+1 | Sixth Street stake in Kpler |
| May 2026 | ROUVY | – | Zwift | Acquisition | Legal adviser to Zwift (acquirer) | Announced | – | Software+1 | Zwift acquisition of ROUVY |
| May 2026 | Perfuse Therapeutics | – | Bayer | Acquisition | Legal adviser to Perfuse Therapeutics (target) | Announced | 300.0 | Biotech+2 | Bayer acquisition of Perfuse Therapeutics |
| Apr 2026 | Document Crunch | – | Trimble | Acquisition | Legal adviser to Document Crunch (target) | Announced | – | Vertical SaaS+2 | Trimble acquisition of Document Crunch |
| Mar 2026 | Aristotle Exchange DCM | – | Underdog Fantasy | Acquisition | Legal adviser to Underdog Fantasy (acquirer) | Announced | – | Exchanges and market infrastructure+2 | Underdog Fantasy acquisition of Aristotle Exchange DCM |
| Feb 2026 | Genes Tech Group Holdings Company | – | Watlow Electric Manufacturing Company | Scheme | Legal adviser to Watlow Electric Manufacturing Company (acquirer) | Completed | – | Hardware & Semiconductors+1 | Watlow Electric Manufacturing Company acquisition of Genes Tech Group Holdings Company |
| Feb 2026 | Orna Therapeutics | – | Eli Lilly and Company | Acquisition | Legal adviser to Orna Therapeutics (target) | Announced | 2,400.0 | Biotech+1 | Eli Lilly and Company acquisition of Orna Therapeutics |
Deals where Justin Pierce is named on the firm's deal team, by the firm or the press.